Latest news: May 2023

Find all of our recent press releases, stay updated with the latest news and be informed about upcoming events where Curium will be attending.

Curium - life forward

26th May 2023

Curium receives positive CHMP opinion of PYLCLARI® for primary staging of patients with high-risk PCa prior to initial curative therapy and to localize recurrence of PCa in patients with a suspected recurrence based on increasing serum Prostate-Specific Antigen (PSA) levels after primary treatment with curative intent

Curium - life forward

23rd May 2023

Curium announces last patient enrolled in their Phase 1/2 SOLAR clinical trial imaging men with histologically-proven metastatic prostate cancer using copper Cu 64 PSMA I&T

Curium - life forward

2nd May 2023

Curasight and Curium announce global partnership for uTRACE® in prostate cancer